Hydroxychloroquine with or without Azithromycin in Covid-19. | N Engl J Med;384(2): 190, 2021 01 14. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Hydroxychloroquine with or without Azithromycin in Covid-19.

Keane, Michael J.

Keane MJ; Swinburne University of Technology, Melbourne, VIC, Australia mkeane@swin.edu.au.

N Engl J Med ; 384(2): 190, 2021 01 14.

Article in English | MEDLINE | ID: covidwho-1243329

Subject(s)

COVID-19 Drug Treatment; Hydroxychloroquine; Azithromycin; Hospitalization; Humans; Hydroxychloroquine/adverse effects; SARS-CoV-2

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Hydroxychloroquine Limits: Humans Language: English Journal: N Engl J Med Year: 2021 Document Type: Article Affiliation country: NEJMc2031780

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Hydroxychloroquine Limits: Humans Language: English Journal: N Engl J Med Year: 2021 Document Type: Article Affiliation country: NEJMc2031780